Skip to main content
. 2018 Jun 23;15(10):1083–1091. doi: 10.7150/ijms.26314

Figure 3.

Figure 3

Melatonin significantly enhances AMPK activation during osteoblast differentiation of human MSCs. (A) Human MSCs were treated with the indicated concentrations of melatonin for 24 h under ODM. (B) Cell were treated with the indicated concentrations of melatonin (100 μM) and compound C for 24 h under ODM. Western blot analysis was performed with the specified antibodies as described in Materials and Methods. Representative data from multiple experiments are shown.